Delhi High Court Refuses To Quash FIR Against Matrix Cellular, Others Accused Of Selling Substandard Oxygen Concentrators During COVID-19

The Delhi High Court allowed the continuation of an FIR against Matrix Cellular for allegedly selling substandard oxygen concentrators during the COVID-19 pandemic. The court emphasized the need for accountability and thorough investigation into the allegations. The case involved a complaint that Matrix Cellular sold defective oxygen concentrators, endangering the lives of patients. The court rejected the company’s plea to quash the FIR, stating that the allegations were serious and warranted a detailed investigation. This ruling underscores the importance of ensuring the quality and safety of medical equipment, especially during public health emergencies.